Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Stephen Malamud"'
Publikováno v:
Cancer Research. 77:P6-09
Background: The 21-gene Oncotype Dx® Recurrence Score (RS) is routinely used to assess the risk of distant recurrence and benefit for adding chemotherapy in the treatment of ER positive HER2 negative early stage breast cancer. Among patients diagnos
Autor:
Theresa Shao, P Klein, Joshua Kra, Stephen Malamud, Anupama Goel, Tiffany Xing, Johnny Chan, Michael L. Grossbard
Publikováno v:
Cancer Research. 75:P3-12
Background: Taxane is an active drug in the treatment of breast cancer, but peripheral neuropathy is a major dose limiting side effect. There are currently no effective drugs or treatment modalities for the prevention or treatment of taxane-related n
Autor:
Peter Homel, Peter Kozuch, Stephen Malamud, Anupama Goel, Michael L. Grossbard, M. Dietrich, Takhir Mirzoyev, Teresa Rodriguez
Publikováno v:
Anti-Cancer Drugs. 18:263-271
Development of treatments to improve the outcomes achieved with single-agent gemcitabine therapy for metastatic pancreatic cancer remains a research priority. G-FLIP (gemcitabine, 5-fluorouracil, leucovorin and cisplatin) is a four-drug regimen desig
Autor:
Ella Dvorkin, Ricardo A. Cruciani, Bruce Culliney, Peter Homel, Jeanne Lapin, Stephen Malamud, Russell K. Portenoy, Nora Esteban-Cruciani
Publikováno v:
Journal of Pain and Symptom Management. 32:551-559
Carnitine deficiency is among the many metabolic disturbances that may contribute to fatigue in patients with cancer. Administration of exogenous L-carnitine may hold promise as a treatment for this common symptom. Little is known about L-carnitine s
Autor:
Azita S. Khorsandi, Louis B. Harrison, Stimson P. Schantz, Roy A. Holliday, Douglas K. Frank, Kenneth S. Hu, Stephen Malamud, Bruce Culliney, Moses Nussbaum, Mark S. Persky, Roy B. Sessions
Publikováno v:
The Laryngoscope. 115:1015-1020
Objectives/Hypothesis: Since 1998, at our academic, multidisciplinary head and neck cancer treatment center, it has been our policy to treat appropriate patients with locoregionally advanced squamous cell carcinoma of the head and neck (SCCHN) with c
Autor:
Michael L. Grossbard, Susan Mathew, M. Dietrich, Peter Kozuch, R. Rachamalla, Stephen Malamud
Publikováno v:
Anti-Cancer Drugs. 15:211-217
This phase I trial was initiated based on encouraging clinical data with 5-fluorouracil (5-FU)/leucovorin (LV), gemcitabine and cisplatin (G-FLIP) in the therapy of solid tumors. In this trial, G-FLIP has been modified to facilitate outpatient admini
Autor:
Sree Bhavani Chalasani, Michael S. Chung, Michael L. Grossbard, Adam J. Olszewski, Peter Kozuch, Stephen Malamud, Tahir Mirzoyev
Publikováno v:
Journal of gastrointestinal cancer. 44(2)
The aims of this study were to establish the maximum tolerated dose (MTD) of oxaliplatin in combination with fixed doses of gemcitabine, irinotecan, and 5-fluorouracil/leucovorin (G-FLIE) in solid tumors, including advanced pancreatic cancer, and to
Autor:
Kenneth S. Hu, Stimson P. Schantz, E. Carper, Louis B. Harrison, G. Sachdeva, Roy B. Sessions, Douglas K. Frank, Mark S. Persky, Stephen Malamud, Bruce Culliney
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 60:S513-S514
Publikováno v:
Cancer investigation. 13(6)
Laboratory studies have suggested that rapidly alternating chemotherapy and radiation therapy might act synergistically. We undertook this study to evaluate the toxicity and effectiveness of this approach in patients with carcinoma involving the hypo